fda news - Search News

Dog Medicine Recall Update As FDA Sets Risk Class

A class II risk level is given to products that "may cause temporary or medically reversible adverse health consequences."

MLive · 15h

7,100 bottles of antidepressant recalled by FDA now in 2nd highest risk class

Duloxetine Delayed-Release Capsules were recalled because the pills may contain high levels of a cancer-causing chemical.

People on MSN · 8h

FDA Has Recalled Thousands of Bottles of Antidepressant Duloxetine, Sold Under Brand Name Cymbalta: Here’s Why

Over 7,100 bottles of Duloxetine were voluntarily recalled by the medication's company beginning Oct. 10 The U.S. Food and Drug Administration has recalled thousands of bottles of the antidepressant Duloxetine for potentially cancer-causing chemicals above the acceptable limit set by the FDA,

New York Post on MSN · 2h

Thousands of bottles of common antidepressant Cymbalta recalled by FDA over cancer-causing chemical

Thousands of bottles of a commonly prescribed antidepressant drug have been recalled by the FDA because they were found to contain a suspected cancer-causing chemical. Over 7,100 bottles of Duloxetine,

Times Now on MSN · 16h

FDA Recalls Thousands Of Duloxetine Antidepressant Bottles | Here's Why

The US Food and Drug Administration has recalled thousands of bottles of Duloxetine antidepressant, saying it contained high levels of a cancer-causing chemical. The federal agency has reportedly upgraded the level of risk.

3hon MSN

FDA says this weight loss drug shortage is over, but patients worry about cost and availability

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

15hon MSN

US FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease

The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract ...

Juice Drinks Recall Update as FDA Sets Risk Level

In an update issued on Tuesday, the FDA classed the recalls as Class II, which is when the "use of or exposure to a violative product may cause temporary or medically reversible adverse health ...

STAT13h

Novo asks FDA to bar compounders from making Ozempic copies

The agency posted documents this week that the drugmaker had requested the drug be placed on the FDA's "Demonstrable ...

US FDA declines to approve Camurus' rare hormone disorder drug

The U.S. Food and Drug Administration has declined to approve Camurus' drug for the treatment of a rare hormonal disorder due ...

FierceBiotech20h

Sangamo slashes time to market for Fabry gene therapy as FDA agrees to accelerated approval package

The biotech engaged with the FDA on alternative pathways to approval after seeing safety and efficacy data from the phase 1/2 ...

STAT19h

Michelle Tarver to lead FDA medical device center

Michelle Tarver will be the new leader of the medical devices center at the Food and Drug Administration, according to an ...

Convenience Store News19h

FDA Seizes 3 Million Unauthorized E-Cigarettes in Joint Federal Operation

The Food and Drug Administration, in collaboration with the U.S. Customs and Border Protection (CBP), seized about three ...

BioPharma Dive15h

FDA names Tarver as new head of device center

Michelle Tarver will officially replace longtime CDRH leader Jeff Shuren, who stepped down from the role earlier this year.

FDA grants marketing authorisation to Peytant’s AMStent system

Peytant Solutions has received marketing authorisation from the US Food and Drug Administration (FDA) for its AMStent ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Related topics